Guardian Capital Advisors LP Lowers Holdings in CME Group Inc. (NASDAQ:CME)

Posted by Defense World Staff on Jun 13th, 2023

Guardian Capital Advisors LP lessened its stake in CME Group Inc. (NASDAQ:CME – Get Rating) by 7.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,135 shares of the financial services provider’s stock after selling 700 shares during the quarter. Guardian Capital Advisors LP’s holdings in CME Group were worth $1,614,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently modified their holdings of CME. RB Capital Management LLC raised its position in shares of CME Group by 11.4% in the 1st quarter. RB Capital Management LLC now owns 1,419 shares of the financial services provider’s stock worth $338,000 after purchasing an additional 145 shares during the last quarter. Prudential PLC purchased a new position in CME Group in the 1st quarter worth about $1,709,000. Cetera Investment Advisers raised its position in CME Group by 5.8% in the 1st quarter. Cetera Investment Advisers now owns 3,485 shares of the financial services provider’s stock worth $829,000 after buying an additional 190 shares during the last quarter. Sequoia Financial Advisors LLC purchased a new position in CME Group in the 1st quarter worth about $281,000. Finally, Candriam Luxembourg S.C.A. raised its position in CME Group by 9.5% in the 1st quarter. Candriam Luxembourg S.C.A. now owns 25,230 shares of the financial services provider’s stock worth $6,001,000 after buying an additional 2,181 shares during the last quarter. Hedge funds and other institutional investors own 85.09% of the company’s stock.

CME Group Trading Down 3.0 %

Shares of NASDAQ:CME opened at $179.35 on Tuesday. The stock has a 50 day moving average of $185.52 and a 200 day moving average of $181.27. The company has a market cap of $64.52 billion, a PE ratio of 22.79, a price-to-earnings-growth ratio of 4.53 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 12-month low of $166.54 and a 12-month high of $212.09.

CME Group (NASDAQ:CME – Get Rating) last announced its quarterly earnings data on Wednesday, April 26th. The financial services provider reported $2.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.36 by $0.06. CME Group had a return on equity of 10.88% and a net margin of 55.99%. The company had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.42 billion. During the same period in the previous year, the company posted $2.11 EPS. The firm’s revenue was up 7.1% on a year-over-year basis. As a group, equities research analysts expect that CME Group Inc. will post 8.73 EPS for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 27th. Shareholders of record on Friday, June 9th will be paid a $1.10 dividend. The ex-dividend date is Thursday, June 8th. This represents a $4.40 annualized dividend and a yield of 2.45%. CME Group’s payout ratio is 55.91%.

Analyst Ratings Changes

A number of equities analysts have weighed in on the company. StockNews.com assumed coverage on CME Group in a research report on Thursday, May 18th. They issued a “hold” rating for the company. Rosenblatt Securities reaffirmed a “sell” rating and set a $161.00 price target on shares of CME Group in a research report on Wednesday, April 5th. JPMorgan Chase & Co. reduced their price target on shares of CME Group from $196.00 to $194.00 and set a “neutral” rating for the company in a research report on Wednesday, April 19th. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $206.00 to $208.00 in a research report on Thursday, April 27th. Finally, Morgan Stanley upped their price target on shares of CME Group from $201.00 to $208.00 and gave the company an “equal weight” rating in a research report on Tuesday, April 11th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $210.50.

CME Group Company Profile

(Get Rating)

CME Group, Inc operates a derivatives marketplace, which offers a range of futures and options products for risk management. Its exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural commodities and metals.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Get Rating).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.